INFECTIOUS COMPLICATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND CORRELATED MYELOID NEOPLASM TREATED WITH AZACITIDINE: AN UNICENTRIC COHORT

Introduction: Although the survival benefit of azacitidine in patients with high-risk myelodysplastic syndrome (MDS), oligoblastic acute myeloid leukemia (AML), and chronic myelomonocytic leukemia (CMML) has been proven, few studies on infections have been published. This study aims to analyze infec...

Full description

Saved in:
Bibliographic Details
Main Authors: AFV Agreda, TDM Pereira, V Buccheri, L Otuyama, J Gasparini, Y Nukui, SF Costa, EDRP Velloso, V Rocha
Format: Article
Language:English
Published: Elsevier 2024-10-01
Series:Hematology, Transfusion and Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137924010952
Tags: Add Tag
No Tags, Be the first to tag this record!